Literature DB >> 9134893

Complement-mediated lung injury and neutrophil retention after intestinal ischemia-reperfusion.

F Xiao1, M J Eppihimer, B H Willis, D L Carden.   

Abstract

Complement-mediated neutrophil activation appears to play an important role in ischemia-reperfusion (I/R) injury in a variety of tissues, including the heart, lung, and small bowel. The objective of this study was to determine whether inhibition of the alternative and classic complement cascades by administration of soluble complement receptor 1 (sCR1) prevents the increased neutrophil stiffness, lung neutrophil retention, and pulmonary microvascular injury elicited by a systemic inflammatory insult. Isolated lungs were perfused with blood obtained from animals subjected to 2 h of intestinal ischemia and 20 min of reperfusion (I/R) or control (nonischemic) surgery. Intestinal I/R resulted in a significant increase in neutrophil stiffness, lung neutrophil retention, and increased pulmonary microvascular permeability, effects that were prevented by administration of sCR1 before intestinal reperfusion. The results of this study suggest that I/R injury in the gut is a potent systemic inflammatory stimulus that induces complement-mediated neutrophil stiffness, lung neutrophil entrapment, and pulmonary microvascular dysfunction.

Entities:  

Mesh:

Year:  1997        PMID: 9134893     DOI: 10.1152/jappl.1997.82.5.1459

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  6 in total

1.  Repertaxin, a novel inhibitor of rat CXCR2 function, inhibits inflammatory responses that follow intestinal ischaemia and reperfusion injury.

Authors:  Danielle G Souza; Riccardo Bertini; Angelica T Vieira; Fernando Q Cunha; Steve Poole; Marcello Allegretti; Francesco Colotta; Mauro M Teixeira
Journal:  Br J Pharmacol       Date:  2004-08-09       Impact factor: 8.739

2.  Identification of a specific self-reactive IgM antibody that initiates intestinal ischemia/reperfusion injury.

Authors:  Ming Zhang; William G Austen; Isaac Chiu; Elisabeth M Alicot; Rachel Hung; Minghe Ma; Nicola Verna; Min Xu; Herbert B Hechtman; Francis D Moore; Michael C Carroll
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-03       Impact factor: 11.205

3.  APT070 (Mirococept), a membrane-localised complement inhibitor, inhibits inflammatory responses that follow intestinal ischaemia and reperfusion injury.

Authors:  Danielle G Souza; Dirk Esser; Roberta Bradford; Angélica T Vieira; Mauro M Teixeira
Journal:  Br J Pharmacol       Date:  2005-08       Impact factor: 8.739

4.  Expression of the adhesion molecules Mac-1 and L-selectin on neutrophils in acute pancreatitis is protease- and complement-dependent.

Authors:  W Hartwig; R E Jimenez; C Fernandez-del Castillo; A Kelliher; R Jones; A L Warshaw
Journal:  Ann Surg       Date:  2001-03       Impact factor: 12.969

5.  Recombinant factor XIII diminishes multiple organ dysfunction in rats caused by gut ischemia-reperfusion injury.

Authors:  Sergey B Zaets; Da-Zhong Xu; Qi Lu; Eleonora Feketova; Tamara L Berezina; Maryann Gruda; Inga V Malinina; Edwin A Deitch; Eva H N Olsen
Journal:  Shock       Date:  2009-06       Impact factor: 3.454

Review 6.  The complement system in ischemia-reperfusion injuries.

Authors:  William B Gorsuch; Elvina Chrysanthou; Wilhelm J Schwaeble; Gregory L Stahl
Journal:  Immunobiology       Date:  2012-08-07       Impact factor: 3.144

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.